虽然MDA确实是全美乃至全球的癌症治疗高峰之一，每天成千上万的临床研究也十分诱人，还有类似詹姆斯艾利森...
The Texas Medical Center is a major contributor to Houston's economy and growth. Several additional factors contributed to the creation of The University of Texas MD Anderson Cancer Center in Houston and its development into one of the most important cancer centers in the world. First was the ...
德州大学安德森癌症中心(University of Texas MD Anderson Cancer Center,UT MDA)是全球著名癌症研究和治疗机构,始建于1941年,是世界公认的权威的肿瘤专科医院,是美国最早的三个综合癌症中心之一,连续30年被《美国新闻与世界报道》评为“癌症护理最好的医院” ,“全美最佳癌症治疗医院”,每年治疗超10万人。 想要出国...
the world’s largest biomedical center. MD Anderson is an equal opportunity/affirmative action employer. Houston is the 4th largest city in the United States with relatively low living
Dr. Youli Zu is a Pathologist in Houston, TX. Find Dr. Zu's phone number, address, insurance information, hospital affiliations and more.
Director, Radiation and Cancer Metabolism Program The University of Texas MD Anderson Cancer Center Unit 1052 1515 Holcombe Blvd Houston, TX 77030 bgan@mdanderson.org 应聘时请将简历抄送一份到:chinayanjiusheng@126.com,邮件标题:应聘单位名称、姓名、学历、专业、博士研究生招聘网...
The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd Houston, TX 77030 https://www.mdanderson.org/research/departments-labs-institutes/labs/hu-laboratory.html 51访学网专注国外访问学者申请服务,已积累不计其数的成功访学案例,如麻省理工学院、哈佛大学、约翰霍普金斯大学、安德森癌症中心、梅奥...
The University of Texas MD Anderson Cancer Center, Houston, TX. Eleni Efstathiou, University of Athens, Athens, Greece. Clinicians are increasingly will... I have only scratched the surface of all that we know about teaching and learning surgical skills. However, the two elements I chose to ...
Clinical Coding Associate(在职员工)-Houston, TX-2024年10月31日 Here at MD Anderson, your job is not only secured, but you also have a lot of opportunities to grow in your career. The management is understanding and caring. They always make sure your voice is heard. They care for employee...
The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for an MD Anderson-sponsored Phase I clinical study of OBX-115